From scientific discoveries to promising clinical trials, City of Hope constantly advances new and better ways to improve the lives of people here and throughout the world.
You can find the latest information on our research, clinical and educational programs through this listing of current press releases.
The first Fred Claire Celebrity Golf Classic will feature an All-Star lineup of former Major League Baseball players and other celebrities at Oakmont Country Club in Glendale, California, on Monday, Aug. 14, with all proceeds going to City of Hope, the world-renowned medical, scientific research and treatment center.
A City of Hope-led study found that the use of low-dose aspirin (81mg) reduces the risk of breast cancer in women who are part of the California’s Teacher’s Study. This study — which is the first to suggest that the reduction in risk occurs for low-dose aspirin — was proposed by City of Hope’s Leslie Bernstein, Ph.D., professor and director of the Division of Biomarkers of Early Detection and Prevention.
City of Hope's Music, Film and Entertainment Industry Group will present its 2017 Spirit of Life® Award to Coran Capshaw. Focused on management, touring, branding, venues, festivals and record label interests, Capshaw is one of the music industry’s most influential and innovative executives. The Spirit of Life® Award is City of Hope’s highest honor, and each year recognizes a leader whose work has fundamentally impacted the music, film or entertainment industries.
A father of three and an aplastic anemia survivor who helped wife beat breast cancer join thousands to thank donors at City of Hope's 41st Annual Bone Marrow Transplant Reunion.
City of Hope researchers believe they may have found a way to prevent graft-versus-host disease after stem cell transplants while retaining the transplants’ positive effects on fighting leukemia and lymphoma.
Studies presented by City of Hope physicians and researchers at the annual meeting of the American Association for Cancer Research (AACR) , could influence future approaches to drug-resistant cancers, treating aggressive brain cancers, recruiting diverse populations for research, and targeted therapies, among other advances.
Linda Malkas, Ph.D., deputy director of basic research for City of Hope who holds the M.T. & B.A. Ahmadinia Professorship in Molecular Oncology, has been appointed to the governing board of the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency.
City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, today announced three new members to its board of directors: Barbara Bruser, senior managing director with First Republic Private Wealth Management, Steven B. Fink, former chief executive officer of Lawrence Investments LLC, and William J. Post, chairman of the board of Translational Genomics Research Institute (TGen).
The stories of patients who have benefited from stem cell therapies funded by the California Institute for Regenerative Medicine (CIRM) will be highlighted at the second symposium of the institute’s Alpha Stem Cell Clinics Network on Thursday, March 23, at City of Hope.
Some type 1 diabetes (T1D) patients can be cured from the disease, at least for a number of years, with a stem cell transplant – those were the results of a clinical trial monitored by City of Hope’s Bart Roep, Ph.D., the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and professor/founding chair, Department of Diabetes Immunology. The results were published recently in the journal, Frontiers in Immunology.